Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I Casal

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Biotechnology & Genetic Engineering Reviews|September 4, 2001
Use of the baculovirus expression system for the generation of virus-like particlesJ I Casal
Cytotechnology|February 24, 2012
Parvovirus diagnostics and vaccine production in insect cellsJ I Casal
Biotechnology and Applied Biochemistry|March 17, 1999
Use of parvovirus-like particles for vaccination and induction of multiple immune responsesJ I Casal
Virology|July 10, 1995
Identification of a linear neutralization domain in the protein VP2 of African horse sickness virusJ L Martínez-Torrecuadrada, J I Casal
Methods (San Diego, Calif.)|October 20, 1999
Parvovirus-like particles as vaccine vectorsJ I Casal, P Rueda, A Hurtado
The Journal of General Virology|March 3, 2004
Influence of flanking sequences on presentation efficiency of a CD8+ cytotoxic T-cell epitope delivered by parvovirus-like particlesP Rueda, G Morón, J Sarraseca, et al.
Vaccine|July 1, 1995
Synthetic peptide vaccines: success at lastR H Meloen, J I Casal, K Dalsgaard, et al.
Journal of Virology|August 1, 1996
Identification of domains in canine parvovirus VP2 essential for the assembly of virus-like particlesA Hurtado, P Rueda, J Nowicky, et al.
Virus Research|October 1, 1995
The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horsesM D Laviada, P Roy, J M Sánchez-Vizcaíno, et al.
The Journal of General Virology|October 1, 1989
Porcine parvovirus: DNA sequence and genome organizationA I Ranz, J J Manclús, E Díaz-Aroca, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Biotechnology & Genetic Engineering Reviews|September 4, 2001
Use of the baculovirus expression system for the generation of virus-like particlesJ I Casal
Cytotechnology|February 24, 2012
Parvovirus diagnostics and vaccine production in insect cellsJ I Casal
Biotechnology and Applied Biochemistry|March 17, 1999
Use of parvovirus-like particles for vaccination and induction of multiple immune responsesJ I Casal
Virology|July 10, 1995
Identification of a linear neutralization domain in the protein VP2 of African horse sickness virusJ L Martínez-Torrecuadrada, J I Casal
Methods (San Diego, Calif.)|October 20, 1999
Parvovirus-like particles as vaccine vectorsJ I Casal, P Rueda, A Hurtado
The Journal of General Virology|March 3, 2004
Influence of flanking sequences on presentation efficiency of a CD8+ cytotoxic T-cell epitope delivered by parvovirus-like particlesP Rueda, G Morón, J Sarraseca, et al.
Vaccine|July 1, 1995
Synthetic peptide vaccines: success at lastR H Meloen, J I Casal, K Dalsgaard, et al.
Journal of Virology|August 1, 1996
Identification of domains in canine parvovirus VP2 essential for the assembly of virus-like particlesA Hurtado, P Rueda, J Nowicky, et al.
Virus Research|October 1, 1995
The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horsesM D Laviada, P Roy, J M Sánchez-Vizcaíno, et al.
The Journal of General Virology|October 1, 1989
Porcine parvovirus: DNA sequence and genome organizationA I Ranz, J J Manclús, E Díaz-Aroca, et al.
Pageof 5